MT1M and hepatocellular carcinoma: To further investigate the expression of ZNF479 and its regulated factors, we examined changes in expression of ZNF479, DNMT1, UHRF1, ASH2L, Menin, MT-1M, MT-1G, and MT-1H in a clinical HCC cohort (including 50 HBV, 50 HCV, and 50 NBNC) samples.